A statistical basis for harmonization of thyroid stimulating hormone immunoassays using a robust factor analysis model by Stockl, Dietmar et al.
DOI 10.1515/cclm-2013-1038      Clin Chem Lab Med 2014; 52(7): 965–972
Dietmar Stöckl, Katleen Van Uytfanghe, Stefan Van Aelst and Linda M. Thienpont*
A statistical basis for harmonization of thyroid 
stimulating hormone immunoassays using 
a robust factor analysis model
Abstract
Background: Between-method equivalence ideally is 
achieved by calibration against an SI-traceable reference 
measurement procedure. For measurement of thyroid 
stimulating hormone (TSH), it is unlikely to accomplish 
this goal in mid-term. Therefore, we investigated a statisti-
cal alternative based on a factor analysis (FA) model.
Methods: The FA model was applied to TSH results for 94 
samples generated by 14 immunoassays (concentration 
range: 0.0005–78 mIU/L). The dataset did not fulfill the 
assumption of a homogeneous sample from an elliptically 
symmetric distribution, and, therefore, required stand-
ardization prior to application of the FA model. As outli-
ers and missing values also occurred, the key quantities of 
the FA model had to be estimated with a method that can 
handle these complications. We selected a robust alter-
nating regressions (RAR) method, which replaces in the 
minimization criterion of the fitting process the squared 
differences between results xij and model fit ˆijx  by a 
weighted absolute difference. The weights are adaptively 
determined in successive regressions, which down weighs 
the outliers. The weights for missing values are set to zero.
Results: The quality of the estimated targets was reflected 
by their central position in the distributions, and descrip-
tion of the relationship between results and targets by a 
simple two-parameter regression equation with high cor-
relation coefficients and low SDs of the percentage-resid-
uals. Mathematical recalibration eliminated the method 
differences and improved the between-method CV from 
11% to 6%.
Conclusions: RAR applied to a multimethod comparison 
dataset hampered by outliers and missing values, is fit to 
the purpose of harmonization.
Keywords: factor analysis model; harmonization; princi-
pal component analysis; robust alternating regressions.
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Introduction
In 2010 the AACC started an initiative to prominently 
promote harmonization of measurands for which no gen-
erally accepted reference measurement procedures (RMPs) 
exist or are under development [1, 2]. A special Task Force 
was mandated with proposing a generic technical harmo-
nization process. One proposal came down to applying a 
new measurement standard, i.e., a panel of native sera 
assigned with targets statistically-derived from a multi-
method intercomparison study [3]. The key to the success 
of this approach lies of course in the use of an adequate 
statistical model. It should assume that each method in 
the comparison tries to measure the same target quantity, 
which may be the true or a hypothetical reference value. 
The quantity is measured with both random and system-
atic errors. While random errors reflect the method impre-
cision, the systematic one, also called the bias, consists 
of a fixed, method-specific and a random, sample-specific 
part. The latter is due to method non-specificity, and, 
hence, depends on the concentration of interfering sub-
stances. The method-specific bias reflects to what extent a 
method consistently over/underestimates the target quan-
tity. Its magnitude is usually not constant, but depends 
on the amount of quantity present in the sample. In the 
absence of a RMP to set trueness-based targets for a split-
sample method comparison, the bias components cannot 
be identified/quantified, nor eliminated, but the statistical 
model can estimate so-called composite reference values 
from the data that can subsequently be used to set each 
method’s results to a common scale [4, 5]. Statistically 
speaking, these values are the realizations of an unob-
servable random variable, called a factor. Henceforth, the 
model is called factor analysis (FA) model involving one 
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factor. Principal component analysis (PCA) is the standard 
approach to estimate the key quantities of the FA model, 
i.e., composite reference values as the (suitably centered) 
scores of the first principal component. However, PCA 
estimates are only reliable if the method comparison data 
are a homogeneous sample that does not contain any out-
liers, missing values, heterogeneity or skewness.
Recalibration against consensus values estimated 
by a FA model to bring multiple sets of results into closer 
mutual alignment has been exemplary described in the 
past, but never knew a real breakthrough [4–6]. Therefore, 
we recently investigated the potential in an application to 
derive the all-procedure trimmed mean from method com-
parison data by several insulin immunoassays [7]. The 
insulin dataset was of particular interest, because it had 
been used before to prove the feasibility of trueness-based 
standardization by adopting a candidate RMP [8]. The 
conclusion was that recalibration against statistically-
derived targets resulted in an equivalent quality compared 
to the RMP approach.
Being involved in an IFCC effort towards standardi-
zation of thyroid stimulating hormone (TSH) assays, 
we took the opportunity to investigate the statistical 
approach to harmonization. Indeed, to the best of our 
knowledge, no SI-traceable RMP is available yet and/
or likely to be on mid- to long-term. From a previous 
method comparison study we knew that most of the 
immunoassays had their calibration set-point within 
10% from the overall mean (apart from a few showing 
discrepancies of approx. 30%–40%), with an excellent 
correlation and low dispersion of regression residuals 
[9]. We found these observations sufficiently convinc-
ing to challenge the technical feasibility of aligning 
TSH immunoassays to target concentrations set by an 
FA model applied on measurement data from a recent 
method comparison. We opted for robust alternating 
regressions (RAR) instead of PCA and emphasize its 
validity to handle our data [10–13]. We verified in partic-
ular whether recalibration to the estimated target values 
adequately removed method-specific biases, so that the 
remaining dispersion nearly entirely could be attributed 
to within-method effects.
Materials and methods
Data collection
TSH data were obtained from a method comparison with 14 
immunoassays and 94 clinical samples (concentration range 
 0.0005–78  mIU/L). Their identity of the assays is not disclosed, 
because this is of no relevance for the statistical study (for a more 
extended rationale, see the Data Supplement that accompanies the 
article at http://www.degruyter.com/view/j/cclm.2014.52.issue-7/
issue-files/cclm.2014.52.issue-7.xml). The samples were analyzed 
in duplicate in the same run. Seven samples with concentrations 
below the most common functional sensitivity ( < 0.012 mIU/L) 
and for which some immunoassays had not reported results, were 
included for statistical estimation of the target values, but excluded 
from validation and recalibration.
Descriptive statistics
The effect of random errors was reduced by working on the mean of 
the replicates. The data were collected in a 94 (rows representing the 
different samples) × 14 (columns for the different methods) matrix. 
The matrix contained 40 missing values (3%).
Measurement heterogeneity and other complications (skewed 
data distributions, outliers) were investigated from presenting the 
data for the individual methods/samples in histograms, box- and 
barplots. In addition, for each method and sample the mean, median 
and SD were calculated as well as the median absolute deviation 
(MAD) given by mad(xi) = med(|xi–med(xi)|).
Statistical approach
We applied the FA model to statistically estimate composite refer-
ence values for the samples. Since our dataset was heterogeneous 
and contained outliers, we first robustly standardized the data by 
using the median and MAD. The target values estimated by the FA 
model were later mapped back to the original data scale. With xij 
being the measurement result of the jth method for the ith sample, 
the FA model containing one factor can be written as xij = αj+βjfi+εij, 
where the values fi are the composite reference values for the sam-
ples. In statistical terms, the values fi are unobservable realizations 
of a latent random variable F. In the FA model it is assumed that the 
method-specific bias of a method j consists of a constant and pro-
portional part referred as αj and βj, respectively. The constant bias is 
the systematic deviation between a method’s measurement and the 
target quantity, and is usually rather small. In contrast, the propor-
tional bias is the systematic deviation that depends on the amount of 
target quantity. The error term εij contains both the imprecision and 
random bias of the method.
We used an alternating regression method that directly esti-
mates the unknown parameters in the FA model by minimizing the 
sum of the deviations between the measured values xij and their cor-
responding model fit α β= +ˆ ˆˆ ˆ .ij j j ix f  To handle missing values, the 
method excludes the corresponding residual in the minimization 
criterion. If the deviations are measured by squared differences, i.e., 
minimize −∑ 2, ˆ( ) ,ij iji j x x  then the alternating least squares regres-
sions technique is obtained [10, 11]. In the robust variant (RAR), the 
squared difference is replaced by a weighted absolute difference, i.e., 
minimized −∑ , ˆ| | .ij ij iji jw x x  The weights wij are determined adap-
tively by the fitting procedure, which down weighs the outliers in 
the successive regression fits [12]. Missing values are still handled by 
exclusion in the minimization criterion, i.e., by setting the weight wij 
equal to zero.
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Assessment of quality
We assessed the validity of the RAR procedure from a statistical point 
of view by making dotplots of the data for each sample by all meth-
ods, with inclusion of the estimated composite reference values. We 
also examined which fraction of the heterogeneity in the measure-
ments can be explained by the FA model. This fraction can be meas-
ured by the robust R-squared, given by 
α
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∑
∑
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In the absence of proportional biases, RR2 is reduced to 0. However, 
in the opposite case, RR2 differs from zero and the FA model can 
explain a substantial fraction of the heterogeneity. We also presented 
the measurement results of each method in a scatter plot versus the 
RAR estimated targets.
To assess the quality of the RAR-derived target concentra-
tions from an analytical point of view, we compared for each of the 
methods the magnitude of the percentage-difference for the indi-
vidual samples from their respective target against total error limits 
derived from biological variation (19.1%) [14]. Second, we did corre-
lation and regression analysis of the results by the immunoassays 
and the estimated target concentrations. Finally, we calculated the 
percentage-residuals for each of the samples, by deriving the ‘pre-
dicted mean of the duplicate’ based on the best fit between the mean 
and the respective target values (using weighted linear regression or 
power functions). The residuals were expressed in percent relative 
to the ‘predicted mean of the duplicate’. We also calculated for each 
method the SD of the percentage-residuals.
Recalibration
We used the RAR-derived target concentrations for mathematical rec-
alibration of the data by each individual method. We applied either 
weighted linear regression or power functions depending on the best 
fit of the data. We verified the quality of recalibration again in per-
centage-difference plots with inclusion of the aforementioned total 
error limits [14]. Finally, we evaluated the pre- and post-recalibration 
between-method variation for the individual samples (‘between-
method CV’). The CV was calculated from the ratio between the SD 
on the results per sample by all methods to the mean. Statistical 
analysis and plotting were done with the freely available advanced 
statistical software R (R core team 2012) version 2.15.1 [15], Microsoft 
Excel® 2010 and CBstat5 (K. Linnet, Denmark).
Results
Descriptive statistics
The boxplots in Figure 1 show that for all methods the 
distribution of the measurement results was strongly 
skewed, and that the spread differed between the 
methods (compare, e.g., the boxplot for methods C and 
E with that for method I). The skewness of the distri-
butions is also reflected by the mean concentration for 
the different methods ranging from 5.3 mIU/L (method I) 
to 8.1 mIU/L (method G), while the range of the 
median  concentrations was from 1.5 mIU/L (method  I) 
to 2.1  mIU/L (method K). The skewness created an 
even larger discrepancy between SDs (ranging from 
11.2  mIU/L to 17.0  mIU/L) and MADs (ranging from 
1.9 mIU/L to 2.5 mIU/L).
The discrepancies between the different methods are 
shown in more detail in the barplots of four particular 
methods (Supplemental Data, Figure S1). For method M, 
the data are generally close to the median, while those 
of method I are consistently below, with a difference 
proportional to the median concentration. The data of 
method K exceed the median, in particular, for samples 
with a higher concentration. The barplot for method G is 
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Figure 1 Boxplot showing the distribution of the measurement results per method.
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an example of a dataset with missing values (17 empty 
bars in total).
The distribution of the results per sample is shown 
in four boxplots (Figure 2). The samples are ranked from 
the lowest to the highest median concentration. These 
boxplots clearly show heteroscedasticity of the spread 
in results between the methods. Moreover, they reveal 
that many samples contain outliers. Outliers were identi-
fied by using the standard rule associated with boxplots, 
i.e., results that lie further than one and a half times the 
interquartile range below or above the box are considered 
outliers. The data heterogeneity is confirmed in the bar-
plots in Supplemental Data, Figure S2. They show the dis-
tribution of the measurements by all methods (A–N) for 
two individual samples. While most of the methods had 
their results close to the median, some deviated consider-
ably (either higher or lower). Note that the empty bar in 
the right plot means that method G did not report a result 
for that sample.
Statistical approach
The histograms and corresponding estimated density 
curves in Figure 3 illustrate that, after robust data stand-
ardization, there is still a lot of heterogeneity in the dis-
tributions of the methods. For example, the histograms 
for methods A, B, H, I still clearly are asymmetric, while 
methods C, E and L contain outlying data. Due to these 
complications, we used iterative RAR to estimate the com-
posite reference values. The procedure converged quickly 
(after only 9 iterations) and the statistically-derived con-
centrations ranged from 0.0005 mIU/L to 78.4 mIU/L.
Assessment of quality
The dotplots in Supplemental Figure S3 show for each 
sample the measurement data by all methods and the 
estimated composite reference value. They illustrate that 
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Figure 2 Boxplots showing the distribution of results per sample.
Note the four different TSH concentration ranges in the ordinate (0.00–0.3 mIU/L; 0.3–1.6 mIU/L; 1.6–5 mIU/L and 5–80 mIU/L). * indicates the 
outliers. Samples are arranged in ascending order of the median concentrations estimated from the measurement data by the 14 methods.
Brought to you by | Universiteit Gent
Authenticated | 10.248.254.158
Download Date | 9/15/14 3:30 PM
Stöckl et al.: Robust factor analysis for harmonization of TSH      969
0.4 A B C D E
F
K L M N
G H I J
0.3
0.2
D
en
si
ty
0.1
0.0
0.4
0.5
0.6
0.3
0.2De
ns
ity
D
en
si
ty
D
en
si
ty
0.1
0.0
0.4
0.3
0.2De
ns
ity
D
en
si
ty
D
en
si
ty
D
en
si
ty
0.1
0.0
0.4
0.3
0.2De
ns
ity
0.1
0.0
0.3
0.2
D
en
si
ty
0.1
0.0
-6 -4 -2 0 2
0.4
0.3
0.2
D
en
si
ty
D
en
si
ty
0.1
0.0
1.0
0.8
0.6
0.4
0.2
0.0
D
en
si
ty
0.6
0.4
0.2
0.0
0.0 0.0
0.2
0.4
0.6
0.8
1.0
0.30
0.20
0.10
0.00
0.1
0.2
0.3
0.4
0.5
0.0
0.1
0.2
0.3
0.4
0.5
D
en
si
ty
0.0
0.1
0.2
0.3
0.4
0.5
0.0 1.0 2.0-1.0
0.00
-10 -5 0 5 50 5-5-10 010
0.10
0.20
0.30
-4 -2 0 2 4
-4 -2 0 2 4 -4 -2
-2 -1 0 1 -2 -1 0 2 31
-5 -4 -3 -2 -2.5 -1.5 -0.5 0.5-1 00 2 4 6
-2 0 2 -5 0 5 10 15 204 6
Figure 3 Histograms with corresponding estimated density curves of the distribution for each of the methods after robust standardization 
of the measurement data.
the latter lies for each sample in the center of the data, 
without being affected by the outlying measurements or 
the heterogeneity in distributions. In addition, a robust 
R-squared of 0.183 was obtained, which means that 18.3% 
of the variability between the methods can be explained 
by proportional deviations from the estimated composite 
reference values.
Supplemental Figure S4 gives for all methods the 
constant and proportional part of the method-specific 
bias estimated by RAR. The scatterplots in Supplemental 
Figure S5 show how well the bias components have been 
estimated by RAR, e.g., for method H, for which the RAR 
procedure estimated a large proportional bias with a con-
stant bias at zero, the scatterplot confirms that most data 
lie above the first bisector and that the distance to the 
line proportionally increases. The scatterplot for method 
M confirms the small biases estimated by RAR. Only for 
method I one sees a large proportional bias in the scat-
terplot (all data for samples with a high concentration are 
below the bisector, thus strongly deviate from the esti-
mated targets), while estimated by RAR it was almost zero.
Figure 4A represents the percentage-difference of the 
results by all immunoassays from the statistically esti-
mated target concentrations before recalibration. Plots 
for the individual methods can be found in Supplemen-
tal Figure S6. Table 1 lists the correlation coefficients, 
the SDs of the percentage-residuals, and the applied 
regression functions. These plots and table show the ana-
lytical quality of the estimated composite reference values 
as a basis for recalibration. Of all data, 86% were within 
the  ± 19.1% biological total error limits, while the data 
for one method (K) were completely out; 95% of the data 
were within  ± 25% limits. The most discrepant percentage-
differences were situated in the low concentration range. 
For the majority of the immunoassays weighted linear 
regression analysis could be applied, while for only three 
immunoassays, a power function was used. The range for 
r was from 0.9946 to 0.9996, for the SDs of the percentage-
residuals from 3.4 to 9.7, with the exception of one outlying 
SD of 18.3 (immunoassay G). Note that this SD was highly 
influenced by the percentage-residuals of the two samples 
with the lowest concentration ( ≤  0.044 mIU/L). After omis-
sion of these samples from the dataset, the SD decreased 
to 7.8%.
Recalibration
Figure 4B represents the percentage-difference plot for 
all immunoassays after mathematical recalibration (for 
the individual plots, see Supplemental Figure S6). All 
immunoassays had the majority of the differences (98% 
of all data) within the biological total error limit. Note in 
addition that even 95% were within  ± 14%. Mathematical 
Brought to you by | Universiteit Gent
Authenticated | 10.248.254.158
Download Date | 9/15/14 3:30 PM
970      Stöckl et al.: Robust factor analysis for harmonization of TSH
recalibration resulted in a considerable decrease in 
between-method CV (Figure 5). For samples with a con-
centration  < 0.15 mIU/L, it decreased in average from 30% 
to approximately 8%, while in the higher concentration 
range from 11% to approximately 6%.
Discussion
The TSH data used in this setting were from a multi-
method comparison study. The purpose was to investigate 
whether consensus values obtained by data treatment 
with a reliable FA model could serve as new measurement 
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Figure 4 Percent-difference plot of the measurement results (mean 
of duplicates) by all immunoassays from the statistically-estimated 
target values.
(A) Before; (B) after mathematical recalibration. Note the logarith-
mic scale of the abscis. Triangles: method K with the highest devia-
tion before recalibration; circles: method I with the lowest deviation 
before recalibration; dashed line:  ± 19.1% total error limit based on 
biological variation.
Table 1 Correlation coefficients, SDs of the percentage-residuals, 
and type of regression function applied.
Method  Correlation 
coefficient
  SD%-residuals  Regression 
function
J   0.9993   3.4  WLRa
H   0.9996   4.4  Power
D   0.9995   5.2  Power
I   0.9982   5.7  WLR
A   0.9993   5.9  Power
M   0.9976   6.3  WLR
N   0.9969   7.3  WLR
E   0.9961   7.9  WLR
B   0.9963   8.1  WLR
C   0.9956   8.7  WLR
L   0.9946   9.5  WLR
K   0.9948   9.5  WLR
F   0.9980   9.7  WLR
G   0.9981   18.3  WLR
aWeighted linear regression.
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Figure 5 Between-method CV observed before and after math-
ematical recalibration.
standard, so that the multiple sets of measurement results 
come in closer alignment. In the FA model, it is assumed 
that the method-specific biases consist of a constant and 
proportional part. Although the assumption of a linear 
relationship between the methods may not be satisfied 
completely, it often is a good first order approximation 
with sufficient accuracy to reliably estimate consensus 
values [4]. Our recalibration data confirmed this.
We first considered PCA, which is the standard esti-
mation procedure for the FA model. It obtains the esti-
mates by decomposition of the covariance matrix of the 
data, implying the assumption of multivariate data being 
a homogeneous sample from an elliptically symmetric 
distribution. We scrutinized our dataset for satisfaction of 
this assumption, which was essential to obtaining unbi-
ased estimates. We started with descriptive statistical data 
Brought to you by | Universiteit Gent
Authenticated | 10.248.254.158
Download Date | 9/15/14 3:30 PM
Stöckl et al.: Robust factor analysis for harmonization of TSH      971
analysis, and found huge heterogeneity. We considered 
transformation techniques to remove the skewness or 
outliers, i.e., logarithmic and more flexible Box-Cox ones, 
however, none were successful. Moreover, such transfor-
mations have a large impact on the relations between the 
methods, which may complicate successive data analy-
sis. Instead, we performed robust data standardization, 
which reduced the skewness in the distributions of all 
methods, but not to the required extent (see the remain-
ing non-symmetric histograms with outliers in Figure 3). 
To reduce the effect of outliers, we could have identi-
fied and trimmed them with a robust PCA method [7, 13]. 
However, this approach requires the existence of a large 
enough homogeneous subsample in the data from which 
the covariance matrix can be estimated. Moreover, still, 
the robust PCA approach is not able to solve the issue of 
missing values. Removal of these samples from data treat-
ment was not an option, because it causes loss of infor-
mation, which in turn may bias the outcome. Therefore, 
we finally decided to apply a robust variant of an alter-
nating regressions method, i.e., RAR. This direct estima-
tion approach does not rely on the covariance matrix of 
the data and can easily handle outliers. In contrast to PCA 
methods, it effectively handles missing values by setting 
their weight wij equal to zero instead of removing an entire 
row (sample) or column (method) from the data matrix. 
We could have considered alternative models, e.g., a 
mixed effects model, i.e., with estimation of a fixed effect 
for each sample and a random effect for each method. The 
former fulfills the role of the consensus value, and allows 
that each assay has the same constant deviation (the latter 
effect) from this value, irrespective of the sample [16–18]. 
However, the heterogeneity, skewness and outliers in our 
data were prohibitive to using this alternative, because 
they do not satisfy the assumptions made by standard 
fitting methods for mixed models, i.e., that due to random 
error effects, the data follow a normal distribution with 
constant variance. Moreover, methods for transformation 
of the data to remove the heterogeneity and/or skewness 
without affecting the validity of the mixed model, are, 
if not impossible, hard to find. Also other assumptions 
about the relations between the methods were not satis-
fied, i.e., that for each sample the variations among the 
methods (after transformation) behave according to some 
fixed regular distribution (usually a normal distribution). 
Although this assumption can be relaxed by including an 
interaction term, it may not be sufficient to capture all het-
erogeneity between the samples. To the best of our knowl-
edge, estimation methods for the mixed model that can 
effectively handle the presence of skewness and outliers 
are not directly available.
For all samples, the composite reference values 
obtained by RAR were lying well in the center of the dis-
tributions. This proves their quality and validity for recali-
bration. The added value of the FA model to explain data 
heterogeneity is confirmed by the fact that nearly 1/5 of 
the between-method heterogeneity could be explained 
by the systematic biases. Thus, not surprisingly, almost 
all methods showed a considerable systematic deviation 
component, apart from method N. The constant and pro-
portional bias part was for most methods well estimated, 
except for method I. Although this apparently conflicts 
with the required robustness of the RAR procedure, it is 
explained by the fact that RAR heavily down weighs all 
data with large deviations from the mean in the high 
concentration range, which of course prevents estima-
tion of the large proportional bias. Notwithstanding this, 
the composite reference values were reliably estimated, 
while the scatterplot reveals the large proportional bias 
afterwards.
Whether recalibration of the methods on the basis 
of the statistical consensus concentrations will result in 
equivalence of results depends not only on the quality of 
the estimates, but also on the influence of the methods’ 
random bias in the process. In this regard, it is important 
that the matrix-specific bias components are maximally 
down weighted, which requires inclusion of as many well-
correlating methods as possible in the intercomparison. 
For heterogeneous analytes, this necessitates investiga-
tion whether all methods measure the same measurand 
by performing cluster analysis [6]. This requirement was 
fulfilled in our study with 14 immunoassays with previ-
ously proven high correlation to the overall mean [9]. We 
confirmed by several means good quality of the estimated 
recalibration basis. First the relationship of the results 
of all immunoassays with the targets could be described 
by a simple two-parameter regression analysis (Table 1). 
In addition the scatter around the regression line was 
good to excellent for the majority of the immunoassays, 
so were the correlation coefficients (min. 0.9946). As a 
result, mathematical recalibration was straightforward 
and eliminated the concentration-dependent differences. 
This was even better reflected by the improvement of the 
between-method CV. In other words, we can claim that 
future implementation of a panel of samples bearing RAR-
estimated target concentrations as new measurement 
standard for harmonization of TSH immunoassays, looks 
promising.
Notwithstanding the success of this study, some 
cautionary notes and limitations need to be stressed. 
First, the input data always will determine the quality of 
the statistical output, thus the success of future, similar 
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studies will depend on interplay of several factors. One 
is the study design requiring use of a high-end panel of 
samples and use of an experimental measurement design 
optimized towards obtaining input data of high quality 
(e.g., replicate measurements of all samples in the same 
run to reduce both random error and calibration effects). 
Also a high correlation between the methods and prefer-
ably homogeneous data distribution are extremely impor-
tant for a successful outcome, because they warrant use 
of a simple best-fitting statistical model and estimates 
with low uncertainty. In case of heterogeneous data com-
plicated by skewed distributions, outliers and/or missing 
values, adequate statistical solutions exist, however, they 
need to be validated for the quality of the estimates. Last 
but not least, statistically-derived target concentrations 
are not necessarily trueness-linked. Therefore, before 
starting any harmonization activity, it is highly recom-
mendable to carefully investigate whether there are no 
standardization efforts in the pipeline.
Acknowledgments: The authors are indebted to the IFCCs 
Committee for Standardization of Thyroid Functions Test 
and the partners from the in-vitro diagnostic industry for 
the inspirational support to conduct this statistical study.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors 
stated that there are no conflicts of interest regarding the 
publication of this article. Research support played no 
role in the study design; in the collection, analysis, and 
interpretation of data; in the writing of the report; or in the 
decision to submit the report for publication.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Received December 2, 2013; accepted January 27, 2014; previously 
published online February 22, 2014
References
1. Miller WG, Myers GL, Gantzer ML, Kahn SE, Schönbrunner ER, 
Thienpont LM, et al. Roadmap for harmonization of clinical 
laboratory measurement procedures. Clin Chem 2011;57:1108–17.
2. Joint Committee for Traceability in Laboratory Medicine (JCTLM) 
Database of higher-order reference materials, measurement 
methods/procedures and services. Available from: http://www.
bipm.org/jctlm/. Accessed 31 July, 2013.
3. Thienpont LM, Van Houcke SK. Traceability to a common standard 
for protein measurements by immunoassay for in-vitro diagnostic 
purposes. Clin Chim Acta 2010;411:2058–61.
4. Lawton WH, Sylvestre EA, Young-Ferraro BJ. Statistical 
comparison of multiple analytic procedures: application to 
clinical chemistry. Technometrics 1979;21:397–409.
5. Carey RN, Wold S, Westgard JO. Principal component analysis: an 
alternative to “referee” methods in method comparison studies. 
Anal Chem 1975;47:1824–9.
6. Rymer JC, Sabatier R, Daver A, Bourleaud J, Assicot M, Bremond J, 
et al. A new approach for clinical biological assay comparison 
and standardization: application of principal component analysis 
to a multicenter study of twenty-one carcinoembryonic antigen 
immunoassay kits. Clin Chem 1999;45:869–81.
7. Van Houcke SK, Van Aelst S, Van Uytfanghe K, Thienpont LM. 
Harmonization of immunoassays to the all-procedure trimmed 
mean – proof of concept by use of data from the insulin standard-
ization project. Clin Chem Lab Med 2013;51:e103–5.
8. Miller WG, Thienpont LM, Van Uytfanghe K, Clark PM, 
Lindstedt P, Nilsson G, et al. Toward standardization of insulin 
immunoassays. Clin Chem 2009;55:1011–8.
9. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller 
WG, et al. Report of the IFCC Working Group for Standardization 
of Thyroid Function Tests, Part 1: Thyroid-stimulating hormone. 
Clin Chem 2010;56:902–11.
10. Wold H. Nonlinear estimation by iterative least squares 
procedures. In: David FN, editor. Research papers in statistics: 
Festschrift for Jerzy Neyman. London: Wiley, 1966;411–44.
11. Gabriel KR, Zamir S. Lower rank approximation of matrices 
by least squares with any choice of weights. Technometrics 
1979;21:489–98.
12. Croux C, Filzmoser P, Pison G, Rousseeuw PJ. Fitting 
multiplicative models by robust alternating regressions. Statist 
Comput 2003;13:23–36.
13. Hubert M, Rousseeuw PJ, Van Aelst S. High-breakdown robust 
multivariate methods. Stat Sci 2008;23:92–119.
14. Westgard QC. Desirable specifications for total error, 
imprecision, and bias derived from biologic variation. Available 
from: http://www.westgard.com/biodatabase1.htm. Accessed 
31 July, 2013.
15. R Core Team. R: a language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, 
Austria. Available from: http://www.R-project.org/. Accessed 31 
July, 2013.
16. Chu H, Chen S, Louis TA. Random effects models in a 
meta-analysis of the accuracy of two diagnostic tests without a 
gold standard. J Am Stat Assoc 2009;104:512–23.
17. Joo DJ, Jung I, Kim MS, Huh KH, Kim H, Choi JS, et al. Comparison 
of the affinity column-mediated immunoassay and microparticle 
enzyme immunoassay methods as a tacrolimus concentration 
assay in the early period after liver transplantation. Transplan 
Proc 2010;42:4137–40.
18. Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, 
Nahm MH, et al. Multilaboratory comparison of Streptococcus 
pneumoniae opsonophagocytic killing assays and their level of 
agreement for the determination of functional antibody activity 
in human reference sera. Clin Vaccine Immunol 2011;18:135–42.
Brought to you by | Universiteit Gent
Authenticated | 10.248.254.158
Download Date | 9/15/14 3:30 PM
